Trabectedin
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Trabectedin Product Information
Trabectedin is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Trabectedin. The product is supplied by Clearsynth under CAT No. CS-O-31170.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Trabectedin
CAS No.
114899-77-3
CAT No.
CS-O-31170
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C39H43N3O11S
Molecular Weight
761.8
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Trabectedin is supplied with detailed characterization data compliant with regulatory guideline. Trabectedin can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Trabectedin.
Overview
"A tetrahydroisoquinoline alkaloid with antitumor activity isolated from the Caribbean tunicate, Ecteinascidin turbinata. It is the first marine anticancer agent approved in the European Union for patients with soft tissue sarcoma (STS). Antineoplastic."
Synonyms
Trabectedin
Application Notes
"A tetrahydroisoquinoline alkaloid with antitumor activity isolated from the Caribbean tunicate, Ecteinascidin turbinata. It is the first marine anticancer agent approved in the European Union for patients with soft tissue sarcoma (STS). Antineoplastic."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.